Tag #Hiv

Showing 121 to 125 of 125 results

it.euronews.com

🌐 75% Global Worthiness

Nov 29, 04:06

Rise in European HIV Diagnoses in 2023

A new report reveals a 2.4% increase in new HIV diagnoses across 47 European countries in 2023, reaching 113,000 cases, despite a global decline; increased testing is cited as a contributing factor, yet around 30% of those with HIV remain undiagnosed.

Rise in European HIV Diagnoses in 2023

A new report reveals a 2.4% increase in new HIV diagnoses across 47 European countries in 2023, reaching 113,000 cases, despite a global decline; increased testing is cited as a contributing factor, yet around 30% of those with HIV remain undiagnosed.

Progress

20% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the overall trend of new HIV diagnoses in Europe in 2023, and what factors contribute to this trend?

In 2023, 113,000 new HIV diagnoses were reported across 47 European countries, a 2.4% increase from 2022. Eight countries—Azerbaijan, Finland, Iceland, Ireland, Kazakhstan, Lithuania, Malta, and Montenegro—recorded their highest annual number of new cases in the past decade. This rise follows a global decrease in new HIV infections between 2010 and 2021.

faz.net

🌐 85% Global Worthiness

Nov 28, 19:07

Injectable HIV PrEP Shows 96% Infection Reduction

Lenacapavir, a new injectable HIV PrEP medication, demonstrated 96% infection reduction compared to daily Truvada in clinical trials, offering improved convenience and addressing stigma, though high cost remains a concern.

Injectable HIV PrEP Shows 96% Infection Reduction

Lenacapavir, a new injectable HIV PrEP medication, demonstrated 96% infection reduction compared to daily Truvada in clinical trials, offering improved convenience and addressing stigma, though high cost remains a concern.

Progress

48% Bias Score

ShareSaveArticle

12345678

Previous 1 of 8 Next

How does Lenacapavir's administration method improve upon existing HIV PrEP strategies and what are the immediate implications?

Lenacapavir, administered as an injection every six months, offers comparable efficacy to daily Truvada tablets for HIV pre-exposure prophylaxis (PrEP). This reduces the frequency of medication and eliminates the stigma associated with daily pill-taking, particularly in high-HIV prevalence areas.

telegraph.co.uk

🌐 % Global Worthiness

Nov 5, 22:10

HIV Treatment Access Barriers in Africa

Challenges faced in accessing HIV treatment in Africa, focusing on financial, social, and logistical barriers.

HIV Treatment Access Barriers in Africa

Challenges faced in accessing HIV treatment in Africa, focusing on financial, social, and logistical barriers.

Progress

0% Bias Score

ShareSaveArticle

12345678910

Previous 1 of 10 Next

Why do many men avoid seeking HIV testing and treatment in Malawi?

Men in Malawi often avoid HIV testing and treatment due to financial burdens, fear of job loss, and societal stigma, resulting in late diagnosis and poorer health outcomes.

sueddeutsche.de

🌐 90% Global Worthiness

Nov 28, 07:08

Semiannual HIV Injection Shows High Efficacy, Poses Access Challenges

A Phase 3 trial shows Lenacapavir, a semiannual HIV prevention injection, is highly effective and comparable to daily Truvada, offering improved adherence and reducing stigma in high-prevalence regions, but its high cost poses a global access challenge.

Semiannual HIV Injection Shows High Efficacy, Poses Access Challenges

A Phase 3 trial shows Lenacapavir, a semiannual HIV prevention injection, is highly effective and comparable to daily Truvada, offering improved adherence and reducing stigma in high-prevalence regions, but its high cost poses a global access challenge.

Progress

40% Bias Score

ShareSaveArticle

12345678

Previous 1 of 8 Next

What are the key challenges and opportunities in ensuring equitable access to Lenacapavir globally?

Lenacapavir's superior convenience addresses the challenges of daily PrEP adherence, particularly the social stigma in high-HIV-prevalence regions where daily pill use may lead to social ostracism. The comparable efficacy to Truvada, along with the twice-yearly injection schedule, positions Lenacapavir as a transformative advancement in HIV prevention.

lemonde.fr

🌐 % Global Worthiness

Nov 7, 10:02

French Court Case: Childhood Trauma and Sexual Assault

A court case in France reveals the traumatic childhood and subsequent offenses of Romain V., a man accused of multiple sexual assaults. The case underscores the devastating impact of childhood trauma and the complexities of criminal justice.

French Court Case: Childhood Trauma and Sexual Assault

A court case in France reveals the traumatic childhood and subsequent offenses of Romain V., a man accused of multiple sexual assaults. The case underscores the devastating impact of childhood trauma and the complexities of criminal justice.

Progress

0% Bias Score

ShareSaveArticle

12345678910

Previous 1 of 10 Next

Describe Romain V.'s childhood experiences.

Romain V.'s childhood involved constant chores, humiliation, and abuse from his violent father and complicit mother. As an adult, his experiences led him to avoid having children out of fear of repeating the family pattern.

Showing 121 to 125 of 125 results